Cardiotoxicity
122
25
33
36
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.6%
8 terminated out of 122 trials
81.8%
-4.7% vs benchmark
9%
11 trials in Phase 3/4
11%
4 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (122)
Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy
The STOP-MED CTRCD Trial
In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Novel On-body Evaluation of Cardiac Health for Oncology
Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer
Artificial Intelligence for Reconstruction of Echocardiography Studies
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Cardiovascular Effects of CART Cell Therapy
Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric Age
Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study
A Study of Blood Pressure Control During Cancer Treatment
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot Study
The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial